The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year.

On August 22, Moderna announced that FDA approved ... On the same day, Pfizer and BioNTech also announced that they received approval for their sBLA for an updated composition of their Omicron ...

When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here's what ...

Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, ...

Respiratory virus season is fast approaching, which means an uptick in flu, COVID-19 and RSV cases. But there are vaccines that can protect you against all three of these diseases, including a new ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

The FDA authorized an updated version of the protein-based Novavax COVID-19 vaccine for use in people 12 and up. Doses could ...

The Hawaii Department of Health is recommending residents get updated flu and COVID-19 vaccines that are now available.

Its cost savings would include a cut of $1.1 billion from research and development from 2026, with most of the actions in ...

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, ...